Research about panaxtrial saponins on the relationship between cerebral ischemic tolerance and proliferation of endogenous neural stem cells

Chinese Journal of Tissue Engineering Research

Volumn 18, Issue 37, 2014, Pages 6014-6018

  Jiang, Xiao Feng ^a   Zhang, Jie Wen ^a   Luo, Zu Ming ^b  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Brain ischemia; Ginsenosides; Infarction; Middle cerebral artery; Panax notoginseng

Indexed keywords

PANAXTRIAL SAPONIN; SAPONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; HIPPOCAMPUS; ISCHEMIC PRECONDITIONING; NEURAL STEM CELL; NONHUMAN; RAT;

EID: 84928821131     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.2095-4344.2014.37.020     Document Type: Article

References (21)

1. Brott T, Bogousslavsky J. Treatment of acute ischemic stroke. N Engl J Med. 2000;343(10):710-722.
2. Antoine H, Roger S. Ischemic preconditioning: introduction. Stroke. 2004;35:2675.
3. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124-1136.
4. Kitagawa K, Matsumoto M, Kuwabara K, et al. 'Ischemic tolerance' phenomenon detected in various brain regions. Brain Res. 1991;561(2):203-211.
5. Dempsey RJ, Sailor KA, Bowen KK, et al. Stroke-induced progenitor cell proliferation in adult spontaneously hypertensive rat brain: effect of exogenous IGF-1 and GDNF. J Neurochem. 2003;87(3):586-597.
6. Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84-91.
7. Ara J, De Montpellier S. Hypoxic-preconditioning enhances the regenerative capacity of neural stem/progenitors in subventricular zone of newborn piglet brain. Stem Cell Res. 2013;11(2):669-686.
8. Jin K, Minami M, Lan JQ, et al. Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc Natl Acad Sci U S A. 2001;98(8):4710-4715.
9. Wei L, Fraser JL, Lu ZY, et al. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol Dis. 2012;46(3):635-645.
10. Dhodda VK, Sailor KA, Bowen KK, et al. Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. J Neurochem. 2004;89(1):73-89.
11. Hong SJ, Li H, Becker KG, et al. Identification and analysis of plasticity-induced late-response genes. Proc Natl Acad Sci U S A. 2004;101(7):2145-2150.
12. Sun Y, Jin K, Xie L, et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 2003;111(12):1843-1851.
13. Türeyen K, Vemuganti R, Bowen KK, et al. EGF and FGF-2 infusion increases post-ischemic neural progenitor cell proliferation in the adult rat brain. Neurosurgery. 2005;57(6): 1254-1263.
14. Sakata H, Niizuma K, Yoshioka H, et al. Minocycline-preconditioned neural stem cells enhance neuroprotection after ischemic stroke in rats. J Neurosci. 2012;32(10):3462-3473.
15. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333(24):1581-1587.
16. Dharmasaroja PA, Pattaraarchachai J. Low vs standard dose of recombinant tissue plasminogen activator in treating East Asian patients with acute ischemic stroke. Neurol India. 2011;59(2):180-184.
17. Cremer S, Berliner Y, Warren D, et al. Successful treatment of pediatric stroke with recombinant tissue plasminogen activator (rt-PA): a case report and review of the literature. CJEM. 2008;10(6):575-578.
18. Stemer AB, Huisa BN, Zivin JA. The evolution of transcranial laser therapy for acute ischemic stroke, including a pooled analysis of NEST-1 and NEST-2. Curr Cardiol Rep. 2010; 12(1): 29-33.
19. Saver JL. Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials. Stroke. 2007;38(11):3055-3062.
20. Wardlaw JM, Murray V, Berge E, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet. 2012;379 (9834): 2364-2372.
21. Naylor M, Bowen KK, Sailor KA, et al. Preconditioning-induced ischemic tolerance stimulates growth factor expression and neurogenesis in adult rat hippocampus. Neurochem Int. 2005;47(8):565-572.